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Purpose: To develop a simple, rapid and improved colorimetric method for the assay of reserpine in 
tablets 
Method: The method is based on the aromatic ring coupling of reserpine with 4-carboxyl-2,6-
dinitrobenzene diazonium ion with the consequent formation of an azo adduct. Optimization of reaction 
conditions and validation were carried out and the method applied to assay of reserpine in tablets. 
Result: Reserpine coupled readily with CDNBD and optimization of experimental conditions showed the 
reaction to be completed in 10 min at room temperature. A 1:1 drug to reagent stoichiometric ratio was 
obtained for the azo adduct formed. The adduct exhibited a bathochromic shift with respect to the drug 
and pronounced hyperchromic shift with respect to the reagent. Sample analyses were done using a 
colorimeter at 470 nm. The assays were linear and reproducible over the concentration range of 2.25 -
24 µg/mL. The new method was successfully applied in the assay of reserpine in tablets with a 
performance similar to the official (USP) spectrophotometric method (p > 0.05). This method represents 
a profound improvement on the previously reported colorimetric method for reserpine. 
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INTRODUCTION 
Reserpine is an alkaloid obtained from the roots 
of certain species of Rauwolfia (Apocyanaceae) 
mainly R. serpentina and R. vomitoria or by 
synthesis. The material obtained from natural 
sources may contain closely related alkaloids 1. 
Descriptions of the medicinal use of the root of 
Rauwolfia serpentina (Benth.), a climbing shrub 
indigenous to India, are present in ancient Hindu 
Ayurvedic writings2.  Reserpine has been used 
in the management of hypertension and in 
chronic psychoses such as schizophrenia. It has 
also been tried in the management of Raynaud’s 
syndrome 
Chemically, reserpine is (3β, 16β, 17α, 18β, 
20α)-11, 17-dimethoxy-18 [(3, 4, 5-
trimethoxybenzoyl)-oxyl] yohimban-16-carboxylic 
acid methyl ester or 3,4,5-trimethoxybenzoyl 
methyl reserpate3. Only the active 
pharmaceutical ingredient is official in the BP 
2002 4 and determined by a UV procedure after 
nitrosation. The USP 24/NF 195, uses a UV 
method for all Rauwolfia preparations after 
exhaustive and extensive solvent extraction. 
Other multi-ingredient preparations containing 
reserpine are assayed by HPLC methods in the 
USP 24/ NF 19. The determination of reserpine 
and other indole alkaloids from Rauwolfia 
serpentina and R. vomitoria by HPLC and 
HPTLC has been reported. Best separation on 
HPLC was achieved with 10% CH3CN and 0.1% 
trifloroacetic acid in water6. Qualitative and 
quantitative analyses of a reserpine-
chlorothiazide mixture in two steps by HPLC 
have also been described7. Other 
chromatographic procedures are also 
described8. 
 
Many flourimetric procedures have been 
described for reserpine either in bulk, dosage 
forms or in biological fluids. Agents that have 
been used include hydrogen peroxide, selenious 
acid, p-toluenesulphonic acid and vanadium 
pentoxide9, hexa-amine cobalt (III) tricarbanato 
cobaltate10 and 2-iodoxybenzoate in aqueous 
acetic acid11. A flow-injection assembly has also 
been adopted following fluorescence 
derivatization11. 
A chemiluminometric determination of reserpine 
and two other Rauwolfia alkaloids, rescinnamine 
and yohimbine based on reaction with 
KMnO4/polyphosphoric acid has been 
described12. 
 
Extraction of reserpine into chloroform from pH 
4.0 phosphate buffer and then ion-pair formation 
with bromocresol purple or methyl orange have 
also been reported9. 
 
The most commonly used colorimetric procedure 
for reserpine involved oxidation of the compound 
to 3,4-didehydroreserpine with sodium nitrite and 
measurement of the absorbance of oxidation 
product at about 390nm. Oxidation of reserpine 
with nitrite in acetic acid followed by extraction 
into chloroform has also been done. Reserpine 
has also been analysed colorimetrically by 
reaction with vanillin, aminopyrimidine, 
xanthydrol (50 - 500µg), phenylisocyanate, 
iodine and sodium glyoxalate9.  
Many of the above mentioned procedures suffer 
from the disadvantages of complexity of method, 
extensive solvent extraction and are time 
consuming. In continuation of our work on the 
development of relatively simple colorimetric 
methods for the assessment of organic 
compounds of pharmaceutical importance13-17, 
we report a new colorimetric method for the 
determination of reserpine in bulk and tablet 
dosage form using the newly developed 4-




Chemicals and Reagents 
Brinerdine (Novartis Pharma SPA Torre 
Annunziata Italy for Novartis Pharma AG Basle, 
Switzerland), Regroton (Norvatis Pharma AG 
Levent-Istanbul), reserpine (CRS number 92808, 
Sandoz Pharma), ethanol, ethylacetate, glacial 
acetic acid, concentrated sulphuric acid, sodium 
nitrite (all analytical reagents from BDH, Poole, 
England), pre-coated thin layer chromatographic 
plates GF254, 0.2mm (Merck, Germany), 4-
amino-3,5-dinitrobenzoic acid (ADBA) 
synthesized in our laboratory. 
Equipment: 
UV/VIS spectrophotometer (Unicam Aurora, 
Helios Scan Software v 1.1, Pye Unicam, 
England), analytical balance H80 (Mettler, UK), 
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ultrasonic bath (Langford Electronics, UK), 
vortex mixer (Griffins and George Ltd, UK), 
digital colorimeter, model 6051 (Jenway, U.K.) 
 
METHOD 
Preparation of stock solutions 
An optimized process was used for the 
preparation of the CDNBD reagent solution 
using ADBA in concentrated sulfuric acid as 
previously reported 20.  
Reserpine stock solution was made by 
dissolving 6mg in 10ml of glacial acetic acid. 
This gave 0.6mg/mL solution. 
 
Optimization studies 
Temperature and reaction time were optimized 
using the method of steepest ascent21. Aliquot of 
the reserpine stock solution (100 µL) was added 
to the reagent solution (500 µL) in a test tube 
and the reaction mixture was mixed in a vortex 
mixer for 10 sec followed by incubation in turn at 
30, 50, 60 and 80oC for 5 and 20 mins.  Each 
determination was carried out in duplicate. The 
reaction was terminated by addition of ice-cold 
water (5mL) to the reaction mixture kept in ice-
bath. The aqueous solution was extracted with 
ethylacetate (5 mL) as previously optimized13 
and kept in a vial wrapped with aluminum foil. A 
blank reagent solution was similarly prepared but 
replacing reserpine stock solution with glacial 
acetic acid. The absorption spectrum of the 
reaction mixture extract was determined against 
the absorption of the blank reagent extract, using 
the UV/VIS spectrophotometer. The absorption 
wavelength, 470 nm, where the difference in 
absorptivity between the adduct and the reagent 
was optimal was selected for sample 
determination on the  colorimeter. 
 The optimal reaction time was determined by 
adding aliquot of reserpine stock solution (100 
µL) in turn to the reagent solution (500 µL) in 
eight test tubes. Coupling reaction was carried 
out by incubation at 60oC for 0, 2, 5, 10, 20, 25 
and 30 minutes. Ethylacetate extracts of the 
reaction mixture was prepared as usual after 
each reaction time and the absorbance was 
measured at 470 nm using the colorimeter. An 
optimum reaction time was then determined as 
the time corresponding to the maximal 
absorption of the samples. All determinations 
were done in duplicates. 
 
Stoichiometric ratio of drug-reagent adduct 
formation: 
Equimolar solutions (0.918 mM) of the reagent 
and the drug stock solution were prepared using 
the procedure described above. Into seven 
different test tubes, 0, 0.25, 0.33, 0.50, 0.67, 
0.75 and 1.0 mL of the reagent solution was 
added respectively. Each tube was then made 
up to 1.0 mL with drug stock solution. Blank 
determinations were similarly carried out using 
glacial acetic acid in place of the drug stock 
solution. The mixtures were mixed on a vortex 
mixer for 10 sec and kept at 30oC for 10 minutes 
and extracted into 5 mL ethylacetate. The 
absorbance was measured at 470 nm against 
the blank and the absorbance values obtained 
were plotted against the mole fraction of the 
reagent solution. Each determination was carried 
out in duplicate. 
 
Assay of dosage forms 
Weight uniformity test was carried out on the two 
brands of the tablet obtained. For Brinerdine(R) 
tablets, an amount of powdered tablet equivalent 
to 0.4mg reserpine was weighed out and 
dissolved in 20 mL chloroform. After dissolution, 
the solution was clarified and 2mL aliquots were 
dried in test tubes. The sample was 
reconstituted in 0.25mL glacial acetic acid and 
then diazotized with 0.5mL of CDNBD reagent 
solution. The sample was treated as before.  
For Regroton ®, an amount equivalent to 0.5mg 
was dissolved in 25mL chloroform and treated 
as Brinerdine®. The USP 2000 
spectrophotometric procedure for reserpine and 
hydrochlorothiazide was adopted as reference 
procedure. 
 
Validation of methods 
Calibration lines using standard solutions of 0, 3, 
6, 12, 18 and 24 µg/mL reserpine were carried 
out using the optimal analytical conditions as 
described above. Linear regression analysis was 
used to calculate the slope, intercept and the 
coefficient of determination (r2) of each 
calibration line. The assay precision and 
accuracy were determined as documented by 
USP 22. The limit of detection was computed as 
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previously described as the analyte 
concentration giving a signal equal to the blank 
signal plus three standard deviations of the 
blank23. 
 
Assessment of method selectivity 
Two approaches were adopted for the 
assessment of the selectivity of this new 
procedure for the assay of reserpine. In the first 
procedure, standard solutions of reserpine 
(12µg/mL) were spiked into each of starch, 
gelatin, lactose, magnesium stearate and a 
mixture of these excipients. Sample analysis 
was done through the optimized procedure 
described for reserpine above. The accuracy 
was compared with that of reserpine reference 
standard solution. In the second approach, 
powdered samples of the two brands of tablets 
investigated and the reserpine reference sample 
were kept at 100oC in the oven for 5 hours. 
Afterwards, methanolic solution of the tablets 
and the reference were analysed for possible 
degradation products. Three separate 
chromatographic systems were adopted [EtOAc: 
MeOH (9:1); EtOAc: MeOH (6:4) and Hex: 
EtOAc (5:5)] in order to reveal the presence of 
any degradation products. 
 
Stability of the azo adduct under diffuse light 
Standard test solutions containing 12µg/mL of 
reserpine were prepared in four sample vials. 
Two of the vials were wrapped with aluminum 
foil, while the other two were left unwrapped. 
Both sets were kept on the laboratory bench. 
The absorbance reading of the extracts at 
470nm were taken at 30 minutes interval for a 
period of three hours. 
 
RESULTS 
Reserpine was found to couple instantly with 
CDNBD and the colour remained stable at room 
temperature for days. The adduct, however, 
lacked fluorescence often inherent in reserpine 
when the TLC plate (containing the adduct and 
pure sample of reserpine) was examined under 
the UV lamp at 365nm. This indicates the 
formation of a new compound. 
The absorption of reserpine, the blank reagent 
and the azo adduct between them is presented 
in Figure 1. Reserpine was found to exhibit a 
major peak at 290nm while there is no significant 
light absorption in the visible region. The 
spectrum of the adduct however revealed a new 
λmax in the visible region at 420nm. The 
maximum difference in the absorptivity between 
the adduct and the reagent was found at 470nm. 
One peculiar feature of the absorption spectrum 
of the adduct is that it appears more of a 
hyperchromic shift when compared with that of 
the reagent (λmax 255, 340 and 430 nm). 
However, the colour of the adduct (reddish-
brown to bright orange) is distinct from that of 
the yellow colour of the reagent. Absorbance of 
the adduct was highest at 30oC and 10 min 
reaction time. Maximum absorbance of the 
adduct was obtained at a mole fraction of 0.5 for 
the reagent solution and the absorbance was 
found to decrease at both lower and higher mole 
fractions. The azo adduct formed by the coupling 
reaction was stable when wrapped for a period 
of 3 hours. There was no significant difference 
between the content of reserpine in the tablets 
assayed by the new method and the USP 
method as shown in Table 1 (p>0.05). The linear 
regression equation for the calibration line under 
the optimal conditions is y = 0.007x + 0.1012 
with a correlation coefficient of 0.9974 (r2 = 
0.9948). The limit of detection for the assay of 
reserpine using CDNBD was found to be 
2.245µg/mL. The 95% confidence limit for the 
slope and intercept are 0.007±0.001 and 
0.1012±0.0091 respectively. Recovery studies 
for the assay of reserpine using the CDNBD 
method were done at concentration levels of 6, 
12, and 18µg/ml.  The three-day assessment of 
the accuracy and reproducibility is presented in 
Table 2. The overall accuracy was found to be 
101.17±3.16 with a coefficient of variation of 
3.12%. The photostability of the reserpine azo 
adduct to diffuse light in ethylacetate done over 
three-hour period revealed that for samples 
exposed to the laboratory atmosphere, the 
absorbance was found to drop gradually to a 
constant value of 0.16 from 90 to 180 minutes. 
The absorbance of the wrapped samples was 
however constant over the three-hour period.  
In the assessment of method selectivity, the 
following recoveries were obtained in the 
presence of the excipients; starch (102.39 ±  
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Overlaid absorption spectra of Reserpine,   (2) Optimization of coupling reaction temperature at two time levels 














































(3) Coupling reaction between CDNBD and reserpine 
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2.51), lactose (103.40±3.1), magnesium stearate 
(103.49 ± 2.90), gelatin (102.69 ± 2.49) and a 
mixture of these excipients (102.39 ±2.51) when 
compared with the reserpine alone (103.9 ± 3.0). 
In the second approach, the tablet samples gave 
a single spot in the three mobile phases 
investigated. It appears that reserpine is 
thermally stable.   
 
DISCUSSION 
The colorimetric determination of reserpine via 
diazo coupling reaction, using CDNBD, is the 
first of such methods to be carried out. While 
most previously reported methods are based on 
measurement of the fluorescence of reserpine, a 
cheaper and readily adaptable colorimetric 
method would be desirable. 
Optimization of coupling reaction temperature 
was investigated at 30, 50, 60 and 80oC at both 
5 and 20 minutes. The optimization of reaction 
temperature is depicted in Figure 2. One 
prominent observation is that at 5 and 20 
minutes, the absorbance of the adduct gradually 
falls after 50oC. At 5 minutes, a very slight 
increase (0.02 absorbance units) was observed 
when the temperature was increased by 20oC 
(i.e. 30oC to 50oC). The absorbance of the azo 
adduct thereafter dropped. Similarly, the 
absorbance at 30oC, 20 minutes is only 0.01 
higher than that at 30oC, 5 minutes. Since a gain 
in time of analysis will be achieved on using the 
most convenient temperature, the room 
temperature of 30oC was selected as the 
temperature for the reaction of reserpine with 
CDNBD. The optimization of coupling time gave 
10 minutes as the optimum time. 
Maximum absorbance for the reserpine azo 
adduct was observed at the mole fraction of 
reagent being 0.5. This implies that the reserpine 
molecule required just a molecule of CDNBD for 
the dye formation. The absorbance gradually 
increased from lower mole fractions of the 
reagent and peaked at 0.5; the value decreased 
thereafter. The 1H NMR of reserpine reveals that 
the proton on the indole ortho (C-12) to the 
methoxyl group is the most shielded24. Thus 
electrophilic attack by CDNBD will be on this 
position. Judging from the spectra observed for 
indomethacin16 which shares the indole nucleus 
with reserpine, the structure of reserpine-
CDNBD adduct is proposed as shown in Figure 
3. This is further corroborated by the 1:1 mole 
ratio obtained between reserpine and CDNBD. 
The recovery studies showed results that 
represent a great improvement over other 
previously reported spectrophotometric methods 
that adopted non-specific reactions for isolation 
and determination of reserpine. This high 
recovery obtained here is comparable with those 
obtained with some flourimetric methods 
especially that described by Walash et al 10 
where the recovery of 100.8±1.4% was obtained. 
The lower concentration value adopted (6 
µg/mL) was found to give the least precise 
results. This can be attributed to the fact that it is 
close to the limit of quantitation (LOQ = 3 x LOD 
= 6.7335 µg/mL). However, better recoveries 
were observed for 12 and 18 µg/ml analyte 
sizes. Since 12 µg/mL represents the midpoint of 
the calibration line and since it also gave 
precision results close to 18 µg/mL concentration 
levels, it was selected as working concentration 
for subsequent analysis.  
The result of the photostability study revealed 
that the new method (CDNBD) has a common 
property with all methods (including the BP and 
USP methods) used for the analysis of reserpine 
and that, all sample solutions be protected from 
light. However, if the analysis could be carried 
out within thirty minutes in the CDNBD method 
only 0.03 absorbance loss will be observed (from 
0.21 at 0 minute to 0.18 at 30 minutes). It can 
therefore be concluded that the azo adduct of 
reserpine is stable up to three hours when 
sample solutions in ethylacetate are wrapped in 
aluminum foil. 
This new procedure described for reserpine for 
the first time offers a great advantage of 
simplicity. It is also the first colorimetric 
procedure for reserpine based on azo dye 
formation. We have previously demonstrated the 
reactivity of CDNBD as a useful agent for the 
detection and assay of phenol ethers 16, 17, 25. 
Essentially, the ability of the method to 
determine reserpine in multicomponent 
formulations without recourse to extensive 
extraction procedure are of great advantage.   
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Table 1: Assay of reserpine in Brinerdin® and Regroton® 
 
Tablet brand CDNBD methoda USP methodb   p-value 
F test   t test 
Brinerdin® 104.3±1.5 101.2±1.7  0.32      0.07 
Regroton® 102.8± 2.5 101.5± 1.4 0.18       0.37 
 
           USP requirement: content of reserpine = 90-110% of labeled amount 
        a; n =5  b; n =4 
 
 
















Mean ± S.D*      RSD% 
 
6 95.0± 6.0                6.3  100.9± 6.0           5.9   98.0± 6.9               7.0 
12 103.9± 3.0              2.9 102.4± 3.4          3.4 103.9 ±3.0             2.9 
18 104.8± 3.8              3.6 101.8± 0              0 99.9±2.3                2.3 
 
                 Between-day statistics = 101.2 ± 3.2% (Mean ± s.e.m), RSD (of  s.e.m) = 3.1% 
* n=9, Regression equation: y = 0.007x + 0.1012 (r2 = 0.9948) 
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This new method via azo dye formation gave 
higher accuracy than the chemiluminometric 
determination of Pinotsis et al 12. When 
compared with the use of vanillin and xanthydrol 
as derivatizing reagents, CDNBD method is 
more sensitive. Another advantage, when 
compared with the reference USP method, is 
that this method offers some degree of 
selectivity. The USP method uses nitrous acid 
generated in situ for nitrosation and any residual 
or contaminant aromatic skeleton will also react. 




This new method for reserpine represents an 
improved approach for its determination. It offers 
the advantages of speed, simplicity and 
selectivity. Moreover, colorimeters are readily 
available and affordable. It is of equivalent 
accuracy with the official procedure and it could 
find application as an in-process analytical 
method for reserpine. The utilization of CDNBD 
as a pre-column derivatization reagent for HPLC 
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